2,404
Participants
Start Date
February 15, 2017
Primary Completion Date
July 5, 2021
Study Completion Date
July 5, 2021
Meningococcal B
Bexsero is indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B.
High-Dose TIV
Fluzone High-Dose is an injectable influenza vaccine made to protect against the flu strains most likely to cause illness for that particular flu season.
Tdap (tetanus-diphtheria-acellular pertussis)
Tdap is a combination vaccine that protects against three potentially life-threatening bacterial diseases: tetanus, diphtheria, and pertussis (whooping cough).
Meningococcal ACWY
Meningococcal ACWY vaccine is indicated for active immunization of individuals up to 55 years of age against invasive meningococcal diseases caused by Neisseria meningitides serogroups A, C, W-135 and Y.
Herpes Zoster
Herpes zoster vaccine is indicated for the immunization of individuals 50 years of age or older for the prevention of herpes zoster (shingles).
Travel Health (Hepatitis A, Hepatitis B, Typhoid Fever)
Hepatitis A vaccine is indicated for immunization against infections caused by hepatitis A virus; Hepatitis B vaccine is indicated for immunization against infection caused by hepatitis B virus; and typhoid fever vaccine is indicated for active immunization against Salmonella typhi, the organism which causes typhoid fever.
IWK Health Centre, Halifax
Collaborators (2)
GlaxoSmithKline
INDUSTRY
MCM Vaccines B.V.
INDUSTRY
Canadian Center for Vaccinology
OTHER
Dalhousie University
OTHER
Canadian Immunization Research Network
NETWORK